Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

AHPA

Avista Public Acquisitio... (AHPA)

Avista Public Acquisition Corporation II
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AHPA
DateHeureSourceTitreSymboleSociété
28/06/202300h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AHPAAvista Public Acquisition Corporation II
26/06/202322h44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AHPAAvista Public Acquisition Corporation II
18/05/202322h39Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AHPAAvista Public Acquisition Corporation II
11/05/202323h12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AHPAAvista Public Acquisition Corporation II
11/05/202312h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AHPAAvista Public Acquisition Corporation II
05/05/202322h04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AHPAAvista Public Acquisition Corporation II
01/05/202315h05Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:AHPAAvista Public Acquisition Corporation II
01/05/202315h03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AHPAAvista Public Acquisition Corporation II
01/05/202315h02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AHPAAvista Public Acquisition Corporation II
31/03/202312h20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AHPAAvista Public Acquisition Corporation II
08/03/202320h16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AHPAAvista Public Acquisition Corporation II
13/02/202318h29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AHPAAvista Public Acquisition Corporation II
07/02/202312h10Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:AHPAAvista Public Acquisition Corporation II
05/01/202323h08Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:AHPAAvista Public Acquisition Corporation II
03/01/202323h00Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AHPAAvista Public Acquisition Corporation II
30/11/202222h54Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:AHPAAvista Public Acquisition Corporation II
23/11/202215h02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:AHPAAvista Public Acquisition Corporation II
14/11/202222h39Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:AHPAAvista Public Acquisition Corporation II
14/11/202222h09Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AHPAAvista Public Acquisition Corporation II
10/11/202223h12Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AHPAAvista Public Acquisition Corporation II
01/11/202221h29Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AHPAAvista Public Acquisition Corporation II
01/11/202215h32Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:AHPAAvista Public Acquisition Corporation II
24/10/202223h00Business WireOmniAb Business Combination Approved by APAC ShareholdersNASDAQ:AHPAAvista Public Acquisition Corporation II
03/10/202214h24Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:AHPAAvista Public Acquisition Corporation II
03/10/202214h00PR Newswire (US)Avista Public Acquisition Corp. II Announces Effectiveness of Registration Statement and Sets Date for Extraordinary General Meeting to Vote on Proposed Business CombinationNASDAQ:AHPAAvista Public Acquisition Corporation II
27/09/202223h02Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:AHPAAvista Public Acquisition Corporation II
24/08/202223h00Business WireLigand Announces that Janssen has Received Approval from European Commission for TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple MyelomaNASDAQ:AHPAAvista Public Acquisition Corporation II
08/08/202222h01Business WireLigand Reports Second Quarter 2022 Financial ResultsNASDAQ:AHPAAvista Public Acquisition Corporation II
16/05/202222h11Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:AHPAAvista Public Acquisition Corporation II
04/05/202222h01Business WireLigand Reports First Quarter 2022 Financial ResultsNASDAQ:AHPAAvista Public Acquisition Corporation II
 Showing the most relevant articles for your search:NASDAQ:AHPA